Host and donor risk factors before and after liver transplantation that impact HCV recurrence
Open Access
- 1 November 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 9 (11) , S44-S47
- https://doi.org/10.1053/jlts.2003.50243
Abstract
Key points: 1. The natural history of hepatitis C after liver transplantation is variable. Several factors, including those related to the virus, the host, the environment and the donor, are probably implicated in the outcome. 2. The immune status per se likely represents the main significant variable in influencing disease severity in hepatitis C virus-infected patients. Findings that support this statement include the higher aggressivity of hepatitis C in immunocompromised liver transplant recipients as compared with that observed in immunocompetent patients, both before and after the development of compensated cirrhosis, and the significant association described between the degree of immunosuppression and disease severity. 3. Similar to that observed in the immunocompetent population, the age at the time of infection (age of the donor) strongly affects posttransplantation hepatitis C virus-related disease progression. 4. Hepatitis C-related disease progression is faster in patients who underwent transplantation in recent years as compared with those who underwent transplantation in earlier cohorts. The increasing age of the donor and the use of stronger immunosuppression may, in part, explain the worse outcomes seen in recent years. 5. Additional host-related variables predictive of outcome include the immunogenetic background, the timing of recurrence, and the early histologic findings.Keywords
This publication has 31 references indexed in Scilit:
- The role of immunosuppression in recurrence of hepatitis CLiver Transplantation, 2003
- The use of hepatitis C-infected grafts in liver transplantationLiver Transplantation, 2003
- Natural history of recurrent hepatitis CLiver Transplantation, 2002
- Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantationLiver Transplantation, 2002
- Anti-Interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantationLiver Transplantation, 2001
- Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patientsLiver Transplantation, 2000
- DONOR POLYMORPHISM OF TUMOR NECROSIS FACTOR GENETransplantation, 1999
- High Incidence of Allograft Cirrhosis in Hepatitis C Virus Genotype 1B Infection Following Transplantation: Relationship With Rejection EpisodesHepatology, 1999
- Histological and clinical outcome after liver transplantation for hepatitis CHepatology, 1997
- Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantationHepatology, 1995